Oxylabs raises $130m from Warburg Pincus at $3.6bn valuation
Oxylabs, the Vilnius-headquartered web-data infrastructure company, has taken a $130 million investment from private equity firm Warburg Pincus, valuing the business at approximately $3.6 billion. The deal marks the first outside capital the company has accepted since its founding in 2015, and is structured through Warburg Pincus Capital Solutions Founders Fund, a vehicle that closed in September 2024 with over $4 billion in commitments.
Oxylabs was founded as a premium proxy provider and has since expanded into what it describes as a full-stack web-data infrastructure platform. The company says it serves more than 350,000 customers across cybersecurity, e-commerce and financial services, including a cohort of Fortune 500 accounts. The transaction involved Goldman Sachs Bank Europe SE as placement agent, with Deloitte Lithuania advising on financial and tax matters and Norton Rose Fulbright, Tegos, and Freshfields among the legal advisers.
Why now
Chief executive Vytautas Savickas framed the round around the growing role of AI agents that access and process live web content at scale. "The next generation of AI won't be powered by static indexes that only capture yesterday's internet," he said. "As AI agents begin to navigate the web far more than humans ever have, the future belongs to the live infrastructure that grounds these systems in real-time, interruption-free knowledge."
Allison Ross, principal at Warburg Pincus, said the firm was backing Oxylabs' position in web intelligence through its "sophisticated technology and expansive network," and cited its blue-chip customer base as a key draw.
The Warburg Pincus Capital Solutions structure is notable. Unlike a standard growth-equity transaction, the founders fund is designed to offer liquidity and balance-sheet flexibility to existing shareholders as well as fresh growth capital. Oxylabs did not disclose how the proceeds are split between primary growth capital and any secondary component, nor did it give specific product-development targets or a path to public markets.
Market context
The web-data and proxy infrastructure market has attracted significant attention as demand for training data and real-time web access grows alongside large-language-model deployments and the emergence of autonomous AI agents. Oxylabs competes in a space that includes Bright Data (formerly Luminati), Smartproxy and a range of niche residential and datacenter proxy providers, as well as newer entrants positioning themselves explicitly as AI-era data platforms.
The agentic AI use case Oxylabs is highlighting is a genuine growth vector. Enterprises building AI agents for competitive intelligence, price monitoring, financial research and compliance workflows require reliable, compliant web access at scale, and infrastructure providers that can demonstrate legal and ethical data-collection practices carry a commercial advantage as regulatory scrutiny of data sourcing tightens. The EU's AI Act and broader GDPR enforcement both place obligations on the provenance and processing of data used to train and run AI systems, a compliance burden that benefits established operators over newer, less-resourced entrants.
Competitive positioning
Oxylabs' eleven-year bootstrapped track record is a credible differentiator in a market where several competitors have cycled through regulatory controversy over the use of residential proxy networks. The company's emphasis on responsible and ethical data collection, while a marketing claim that cannot be independently verified from this release, aligns with the compliance requirements increasingly imposed by enterprise procurement teams and public-sector customers.
The $3.6 billion valuation implies a substantial revenue multiple for a business that has not previously disclosed financial figures. Investors and customers will look for Oxylabs to publish specific product milestones, named enterprise wins, and data on network scale as it absorbs outside capital for the first time.